# Small-Cell Neuroendocrine Cervical Carcinoma Mimicking a Polyp in a 20-Year-Old Patient With a Five-Year Follow-Up: A Case Report

**Authors:** Chau Giang Huynh, Bich-Ha Thi Truong, Truc Thanh Thai, Phuong-Thao Thi Doan

PMC · DOI: 10.7759/cureus.62893 · Cureus · 2024-06-22

## TL;DR

A 20-year-old patient with a rare cervical cancer initially mistaken for a benign polyp was successfully treated and remained cancer-free for five years.

## Contribution

This case report highlights the diagnostic challenges and successful management of a rare small-cell neuroendocrine cervical carcinoma in a young patient.

## Key findings

- The patient showed no metastasis or recurrence after five years of follow-up.
- A combination of chemotherapy and surgery led to favorable outcomes.
- Ovarian preservation was safely performed due to the patient's age and limited disease.

## Abstract

Small-cell neuroendocrine cervical carcinoma (NECC) is a rare histology, and diagnosis and treatment of this condition are challenging because of its rarity, non-specific abdominopelvic symptoms, and less favorable prognosis compared to other cervical cancers. Here, we present a case of a 20-year-old patient diagnosed with small-cell NECC, defined within a cervical polyp, initially mimicking a benign lesion. Because of the difficulty in diagnosis, the patient underwent thorough diagnostics and interventions, including imaging, histopathology, and immunohistochemistry. Initially, the patient underwent a distinctive treatment plan encompassing four cycles of cisplatin and etoposide chemotherapy with minimal side effects. Subsequently, she received comprehensive surgical interventions, including hysterectomy, lymphadenectomy, and bilateral salpingectomy. Ovarian preservation, justified by the patient’s youth and small cervical lesions (<4 cm) without parametrial disease or metastatic signs, was pursued. For long-term outcomes, the patient demonstrated no metastasis or recurrence during a five-year follow-up. This case emphasizes the requirement for strengthened awareness of neuroendocrine tumors in cervical masses, particularly in young patients, and the importance of individualized treatment approaches for optimal clinical outcomes. Continued documentation of such cases increases our understanding of managing infrequent cervical malignancies.

## Linked entities

- **Chemicals:** cisplatin (PubChem CID 5460033), etoposide (PubChem CID 36462)
- **Diseases:** cervical cancer (MONDO:0002974)

## Full-text entities

- **Diseases:** parametrial disease (MESH:D004194), Small-Cell Neuroendocrine Cervical Carcinoma (MESH:D018288), Polyp (MESH:D011127), metastasis (MESH:D009362), NECC (MESH:D018278), neuroendocrine tumors (MESH:D018358), benign lesion (MESH:D001932), cervical cancers (MESH:D002583), cervical lesions (MESH:D002575)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11261534/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11261534/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC11261534/full.md

---
Source: https://tomesphere.com/paper/PMC11261534